QR-Code

Prognostic value of chemotherapy response score in advanced ovarian cancer: a single-center retrospective analysis

ABSTRACT BACKGROUND: The chemotherapy response score (CRS) is a histopathological tool used to assess the tumor response in patients with high-grade serous ovarian carcinoma (HGSC) undergoing neoadjuvant chemotherapy (NACT) followed by interval debulking surgery (IDS). DESIGN AND SETTING: This sin...

Ausführliche Beschreibung

Gespeichert in:
Hauptverfasser: Hamdullah Sözen, Yagmur Minareci, Atahan Toyran, Ibrahim Yalçin, Semen Önder, Aysel Bayram, Sidar Bağbudar, Mustafa Albayrak, Müge Ateş Tikiz, Pınar Mualla Saip, Samet Topuz, Mehmet Yavuz Salihoglu
Format: Artigo
Sprache:Inglês
Veröffentlicht: Associação Paulista de Medicina 2025-10-01
Schriftenreihe:São Paulo Medical Journal
Schlagworte:
Ovarian neoplasms
Neoadjuvant therapy
Survival analysis
Interval debulking surgery
Chemotherapy response score
High-grade serous ovarian carcinoma
Overall survival
Disease-free survival
Online-Zugang:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802025000600208&lng=en&tlng=en
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!

Ähnliche Einträge